Literature DB >> 16255760

Viral load change and sequential evolution of entire hepatitis C virus genome in Irish recipients of single source-contaminated anti-D immunoglobulin*.

J Itakura1, K Nagayama, N Enomoto, K Hamano, N Sakamoto, L J Fanning, E Kenny-Walsh, F Shanahan, M Watanabe.   

Abstract

In hepatitis C virus (HCV) infection, serum viral load is important in the prediction of therapeutic efficacy. However, factors that affect the viral load remain poorly understood. To identify viral genomic elements responsible for the viral load, we investigated samples from a population of Irish women who were iatrogenically infected from a single HCV source by administration of HCV 1b-contaminated anti-D immune globulin between 1977 and 1978 (Kenny-Walsh, N Engl J Med 1999; 340: 1228). About 15 patients were divided into two groups, viral load increasing group (11 patients) and decreasing group (4 patients). Pairs of sera were collected from each patient at interval between 1.1 and 5.8 years. Full-length sequences of HCV genome were determined, and analyzed for changes in each patient. Sliding window analysis showed that the decreasing group had significantly higher mutation rates in a short segment of NS5B region that may affect the activity of RNA-dependent RNA polymerase. By comparing each coding regions, significantly higher mutation numbers were accumulated in NS5A region in the increasing group than the decreasing group (0.92 vs 0.16 nucleotides/site/year, P = 0.021). The mutation in certain positions of the HCV genome may be determinant factors of the viral load in a relatively homogeneous patient population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16255760     DOI: 10.1111/j.1365-2893.2005.00645.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  9 in total

Review 1.  Acute hepatitis C virus infection: a chronic problem.

Authors:  Jason T Blackard; M Tarek Shata; Norah J Shire; Kenneth E Sherman
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

2.  Evidence of distinct populations of hepatitis C virus in the liver and plasma of patients co-infected with HIV and HCV.

Authors:  Jason T Blackard; Gang Ma; Satarupa Sengupta; Christina M Martin; Eleanor A Powell; M Tarek Shata; Kenneth E Sherman
Journal:  J Med Virol       Date:  2014-04-30       Impact factor: 2.327

3.  The mode and tempo of hepatitis C virus evolution within and among hosts.

Authors:  Rebecca R Gray; Joe Parker; Philippe Lemey; Marco Salemi; Aris Katzourakis; Oliver G Pybus
Journal:  BMC Evol Biol       Date:  2011-05-19       Impact factor: 3.260

4.  Variability of the polymerase gene (NS5B) in hepatitis C virus-infected women.

Authors:  Jason T Blackard; Gang Ma; Berkeley N Limketkai; Jeffrey A Welge; Peter D Dryer; Christina M Martin; Yoichi Hiasa; Lynn E Taylor; Kenneth H Mayer; Denise J Jamieson; Kenneth E Sherman
Journal:  J Clin Microbiol       Date:  2010-09-01       Impact factor: 5.948

5.  Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization.

Authors:  Jason T Blackard; Gang Ma; Jeffrey A Welge; Christina M Martin; Kenneth E Sherman; Lynn E Taylor; Kenneth H Mayer; Denise J Jamieson
Journal:  J Med Virol       Date:  2012-02       Impact factor: 2.327

6.  Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection.

Authors:  Karen Fitzmaurice; Danijela Petrovic; Narayan Ramamurthy; Ruth Simmons; Shazma Merani; Silvana Gaudieri; Stuart Sims; Eugene Dempsey; Elizabeth Freitas; Susan Lea; Susan McKiernan; Suzanne Norris; Aideen Long; Dermot Kelleher; Paul Klenerman
Journal:  Gut       Date:  2011-05-06       Impact factor: 23.059

7.  Occurrence of genetic modifications in core, 5'UTR and NS5b of HCV associated with viral response to treatment.

Authors:  Sobia Kanwal; Tariq Mahmood
Journal:  Virol J       Date:  2014-09-30       Impact factor: 4.099

8.  Dissection of two drug-targeted regions of Hepatitis C virus subtype 4a infecting Egyptian patients.

Authors:  Radwa R El-Tahan; Ahmed M Ghoneim; Hosam Zaghloul
Journal:  Virus Genes       Date:  2020-06-22       Impact factor: 2.332

9.  Socio-demographic and clinical features of Irish iatrogenic hepatitis C patients: a cross-sectional survey.

Authors:  Olivia McKenna; Caitriona Cunningham; Catherine Blake
Journal:  BMC Public Health       Date:  2009-09-07       Impact factor: 3.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.